Search Results - Jan-Inge Henter

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis by Malin Sveijer, Désirée Gavhed, Helena Hertzberg, Eric Zander, Jan-Inge Henter, Tatiana von Bahr Greenwood

    Published in Blood Neoplasia (2025-08-01)
    Get full text
    Article


  2. 2

    Targeting BCL2 Family in Human Myeloid Dendritic Cells: A Challenge to Cure Diseases with Chronic Inflammations Associated with Bone Loss by Selma Olsson Åkefeldt, Mohamad Bachar Ismail, Hélène Valentin, Maurizio Aricò, Jan-Inge Henter, Christine Delprat

    Published in Clinical and Developmental Immunology (2013-01-01)
    Get full text
    Article


  3. 3

    Longitudinal strain analysis for assessment of early cardiotoxicity during anthracycline treatment in childhood sarcoma: A single center experience by Maria Sjöborg Alpman, Annica Jarting, Kerstin Magnusson, Aristomenis Manouras, Jan‐Inge Henter, Agneta Månsson Broberg, Nikolas Herold

    Published in Cancer Reports (2023-09-01)
    Get full text
    Article


  4. 4

    Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity by Xiangling Wang, Astrid Ottosson, Chunyan Ji, Xiaoli Feng, Magnus Nordenskjöld, Jan-Inge Henter, Bengt Fadeel, Chengyun Zheng

    Published in Haematologica (2009-04-01)
    Get full text
    Article


  5. 5

    Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome by Karin Palmblad, Hanna Schierbeck, Erik Sundberg, Anna-Carin Horne, Helena Erlandsson Harris, Jan-Inge Henter, Ulf Andersson

    Published in Molecular Medicine (2021-05-01)
    Get full text
    Article


  6. 6

    Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions by Jenée Mitchell, Jenée Mitchell, Egle Kvedaraite, Egle Kvedaraite, Egle Kvedaraite, Tatiana von Bahr Greenwood, Tatiana von Bahr Greenwood, Magda Lourda, Magda Lourda, Jan-Inge Henter, Jan-Inge Henter, Stuart P. Berzins, Stuart P. Berzins, George Kannourakis, George Kannourakis

    Published in Frontiers in Pediatrics (2022-06-01)
    Get full text
    Article


  7. 7

    Development of classical Hodgkin’s lymphoma in an adult with biallelic STXBP2 mutations by Maciej Machaczka, Monika Klimkowska, Samuel C.C. Chiang, Marie Meeths, Martha-Lena Müller, Britt Gustafsson, Jan-Inge Henter, Yenan T. Bryceson

    Published in Haematologica (2013-05-01)
    Get full text
    Article


  8. 8

    Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies by Kai Lehmberg, Kim E. Nichols, Jan-Inge Henter, Michael Girschikofsky, Tatiana Greenwood, Michael Jordan, Ashish Kumar, Milen Minkov, Paul La Rosée, Sheila Weitzman

    Published in Haematologica (2015-08-01)
    Get full text
    Article


  9. 9

    Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions. by Jennifer A West, Sharon L Olsen, Jenée M Mitchell, Ross E Priddle, Jennifer M Luke, Selma Olsson Akefeldt, Jan-Inge Henter, Christopher Turville, George Kannourakis

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  10. 10

    Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series by Jack J. Scala, Michael J. Eckrich, Keagan Lipak, Bonnie Yates, Constance Yuan, Hao-Wei Wang, Saurabh Dahiya, Jan-Inge Henter, Jeffrey S. Huo, Matthew J. Frank, Nirali N. Shah

    Published in Haematologica (2024-05-01)
    Get full text
    Article


  11. 11

    Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells by Daniel W. Hagey, Egle Kvedaraite, Mira Akber, André Görgens, Joman Javadi, Tatiana von Bahr Greenwood, Caroline Björklund, Selma Olsson Åkefeldt, Tova Hannegård-Hamrin, Henrik Arnell, Katalin Dobra, Nikolas Herold, Mattias Svensson, Samir EL Andaloussi, Jan-Inge Henter, Magda Lourda

    Published in Haematologica (2023-03-01)
    Get full text
    Article


  12. 12

    Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial by Jonas Sundén-Cullberg, Puran Chen, Henrike Häbel, Paul Skorup, Helena Janols, Johan Rasmuson, Katarina Niward, Åse Östholm Balkhed, Katerina Chatzidionysiou, Hilmir Asgeirsson, Ola Blennow, Åsa Parke, Anna-Karin Svensson, Jagadeeswara Rao Muvva, Hans-Gustav Ljunggren, Anna-Carin Horne, Ulrika Ådén, Jan-Inge Henter, Anders Sönnerborg, Jan Vesterbacka, Piotr Nowak, Jon Lampa

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  13. 13

    Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy by Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday, Nikolas Herold

    Published in EMBO Molecular Medicine (2020-01-01)
    Get full text
    Article


  14. 14

    Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF by Egle Kvedaraite, Magda Lourda, Natalia Mouratidou, Tim Düking, Avinash Padhi, Kirsten Moll, Paulo Czarnewski, Indranil Sinha, Ioanna Xagoraris, Efthymia Kokkinou, Anastasios Damdimopoulos, Whitney Weigel, Olga Hartwig, Telma E. Santos, Tea Soini, Aline Van Acker, Nelly Rahkonen, Malin Flodström Tullberg, Emma Ringqvist, Marcus Buggert, Carl Jorns, Ulrik Lindforss, Caroline Nordenvall, Christopher T. Stamper, David Unnersjö-Jess, Mira Akber, Ruta Nadisauskaite, Jessica Jansson, Niels Vandamme, Chiara Sorini, Marijke Elise Grundeken, Helena Rolandsdotter, George Rassidakis, Eduardo J. Villablanca, Maja Ideström, Stefan Eulitz, Henrik Arnell, Jenny Mjösberg, Jan-Inge Henter, Mattias Svensson

    Published in Nature Communications (2024-02-01)
    Get full text
    Article


  15. 15

    Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis by Francesco Pegoraro, Francois Chalard, Dmitry Evseev, Mohamed Barkaoui, Solenne Le Louet, Julian Thalhammer, Nathalie Aladjidi, Alexandra Salmon, Perrine Marec‐Berard, Stefania Gaspari, Carmela De Fusco, Irene Trambusti, Antonio Verrico, Anna Raciborska, Karel Svojgr, Zdenka Křenová, Olga Slater, Gerard Millen, Myriam Ben Arush, Dana Ashkenazi Lustig, Tatiana Von Bahr Greenwood, Caroline Hutter, Itziar Astigarraga, Mónica López‐Duarte, Lorena Valero‐Arrese, María José Ortega Acosta, Cor van den Bos, Leonie Naeije, Daniel Martin‐Munoz, Anna Perrone, Marzia Mortilla, Olivier Felician, Ahmed Idbaih, Sébastien Héritier, Vasanta Nanduri, Milen Minkov, Jan‐Inge Henter, Elena Sieni, Jean Donadieu

    Published in HemaSphere (2026-06-01)
    Get full text
    Article


Search Tools: